PARP1 and infection: Our data demonstrates two main consequences of RSV-mediated PARP1 activation: (1) alteration of DC cellular metabolism during the early phase of infection results in the suppression of antiviral properties and (2) enhancement of viral-induced pulmonary pathology includes airway inflammation and mucus hypersecretion.